Literature DB >> 1165596

Adenovirus gene function required for induction of nuclear acidic protein synthesis: binding of these proteins to adenovirus DNA.

N Ledinko.   

Abstract

Two different viral DNA-defective temperature-sensitive mutants of adenovirus 12 (H 12) were defective in their ability to induce the synthesis of various molecular weight classes of nuclear acidic proteins, both virion and nonvirion components, after lytic infection of human embryo kidney (HEK) cells at the restrictive temperature. This finding indicates that the induction of nuclear acidic protein synthesis is an adenovirus gene function(s). Treatment of infected cells with actinomycin D at an early stage of virus maturation suppressed the synthesis of an acidic virion protein (hexon), but allowed the synthesis of other classes of nuclear nonvirion acidic proteins during the subsequent late maturation period, suggesting that different mechanisms control virion and nonvirion polypeptide synthesis. The interaction of the nuclear acidic proteins isolated from H 12-infected cells with native-labeled H 12 DNA was studied using the membrane filter technique. Measurements of the ability of different DNA preparations to inhibit the H 12 DNA-acidic protein complex formation suggest that the nuclear acidic proteins bound to native H 12 or HEK cell DNA with much higher affinity than to native calf thymus DNA. Moreover, native H 12 DNA was able to bind the acidic proteins more efficiently than did denatured H 12 DNA. The acidic proteins isolated from the cytoplasm of H 12-infected cells bound approximately 100-fold less to native H 12 DNA than did the nuclear proteins. Furthermore, the H 12 DNA binding affinity of the nuclear acidic proteins from uninfected cells, or from H 12-infected and 1-beta-D-arabinofuranosylcytosine-treated cells, was somewhat lower than that of the nuclear proteins from infected (untreated) cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165596      PMCID: PMC354739     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  The selectivity of transcription.

Authors:  M J Chamberlin
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

3.  Modifications in the chromosomal proteins of SV-40 transformed WI-38 human diploid fibroblasts.

Authors:  M O Krause; G S Stein
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

4.  Acidic nuclear protein synthesis in Rous Sarcoma virus infected chick embryo fibroblasts.

Authors:  G S Stein; G Moscovici; C Moscovici; M Mons
Journal:  FEBS Lett       Date:  1974-01-15       Impact factor: 4.124

5.  Immunospecificity to non-histone chromosomal proteins of anti-chromatin antibodies.

Authors:  L Zardi; J C Lin; R Baserga
Journal:  Nat New Biol       Date:  1973-10-17

6.  Nonhistone chromosomal proteins and gene regulation.

Authors:  G S Stein; T C Spelsberg; L J Kleinsmith
Journal:  Science       Date:  1974-03-01       Impact factor: 47.728

7.  Early increase in nuclear acidic protein synthesis after SV40 infection.

Authors:  G Rovera; R Baserga; V Defendi
Journal:  Nat New Biol       Date:  1972-06-21

8.  Studies of nuclear acidic proteins. Evidence for their phosphorylation, tissue specificity, selective binding to deoxyribonucleic acid, and stimulation effects on transcription.

Authors:  C S Teng; C T Teng; V G Allfrey
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

9.  The synthesis of acidic nuclear proteins in the prereplicative phase of the isoproterenol-stimulated salivary gland.

Authors:  G Stein; R Baserga
Journal:  J Biol Chem       Date:  1970-11-25       Impact factor: 5.157

10.  DNA-binding proteins specific for cells infected by adenovirus.

Authors:  P C van der Vliet; A J Levine
Journal:  Nat New Biol       Date:  1973-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.